Home › Markets › Health Care › ACHC

Acadia Healthcare Company Inc. (ACHC)

ACHC trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$30.23
+0.50% on the day
Market cap
$2.8B
Mid cap
Revenue · 2025
$3.3B
+5.0% on 2024
Net income · 2025
-$1.1B
-33.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerACHC on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001520697
SEC industry codeServices-Specialty Outpatient Facilities, NEC
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.3B
Net income-$1.1B
Operating incomeNot in SEC XBRL data
Net margin-33.3%
Operating marginOperating income not reported
Revenue growth+5.0%
Cash$133.2M
Total assets$5.5B
P/E (computed)Net income was not positive
P/S (computed)0.8×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B72017-08-18
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-07-28
Latest current report
FORM 8-K
8-K2026-09-25
Latest proxyDEFA14A2026-03-25

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+8.3%
1 month+15.7%
3 months-5.8%
Year to date+123.2%
1 year+30.4%
From 52-week high-11.1%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
CELCCelcuity Inc.$63.19-4.04%$3.1B
CLOVClover Health Investments Corp.$4.81+0.63%$2.6B
CDNACareDx Inc.$65.43+3.66%$3.4B
VCYTVeracyte Inc.$43.11-2.07%$3.5B
FTREFortrea Holdings Inc.$20.92-0.38%$2.0B
BLLNBillionToOne Inc.$94.44+1.47%$4.5B
ALHCAlignment Healthcare Inc.$8.30+2.60%$1.7B
PSNLPersonalis Inc.$15.85+0.32%$1.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier